0
By clicking the button, I accept the Terms of Use of the service and its Privacy Policy, as well as consent to the processing of personal data.
Don’t have an account? Signup
Denmark-based Novo Nordisk has reached an agreement to acquire Cardior Pharmaceuticals for 1.025 billion Euros ($1.1 billion). The deal includes an upfront payment and additional payments if predetermined commercial and development milestones are met.
Share this article
If you liked this article share it with your friends.they will thank you later
/medriva/media/media_files/A2n50yT8fx1Q1UZcWfhK.jpg)
3 Min read
/medriva/media/post_banners/content/uploads/2023/12/mortality-rates-for-11-common-health-conditions-in-hospital-settings-pennsylvania-20231216050912.jpg)
/medriva/media/post_banners/content/uploads/2023/12/transcatheter-tricuspid-repair-triluminate-trial-analysis-20231214192644.jpg)
/medriva/media/post_banners/content/uploads/2023/12/stem-cell-based-therapy-for-heart-failure-mayo-clinic-20231213131521.jpg)
/medriva/media/post_banners/content/uploads/2023/12/mit-robotic-right-ventricle-20231209130833.jpg)
/medriva/media/post_banners/content/uploads/2023/11/The-Intricate-Link-Understanding-the-Relationship-between-Iron-Deficiency-and-Heart-Rate.png)
/medriva/media/post_banners/content/uploads/2023/11/Unraveling-the-Mystery-Understand-What-Causes-Water-Retention-and-How-to-Combat-It.png)
/medriva/media/agency_attachments/PAJ1yimoQnd9vBc8FTrz.png)
/medriva/media/media_files/JW1Y2Cm26JYNPS4FZ4Gq.png)